Literature DB >> 26156031

Intermittent insulin treatment mimics ischemic postconditioning via MitoKATP channels, ROS, and RISK.

Erik Helgeland1, Lars Breivik, Balindiwe J Sishi, Anna-Mart Engelbrecht, Anne K Jonassen.   

Abstract

OBJECTIVES: It has previously been demonstrated that 15-min continuous insulin infusion at immediate reperfusion affords cardioprotection. This study sought to reduce the treatment time of insulin and test if intermittent insulin infusions can mimic ischemic postconditioning.
DESIGN: In a Langendorff perfused rat heart model of regional ischemia, hearts were at the onset of reperfusion subjected to either 5- or 1-min continuous insulin infusion or 3 × 30 s intermittent insulin infusions (InsPost); with or without inhibitors of Akt (SH-6), p70s6-kinase (rapamycin), mitochondrial ATP-sensitive potassium channels (5-hydroxydecanoic acid [5-HD]), or a scavenger of reactive oxygen species (ROS; 2-mercaptopropionyl glycine [MPG]). Infarct size is expressed as percent of area at risk and presented as mean ± standard error of the mean or s.e.m.
RESULTS: Only InsPost was able to reduce infarct size compared with controls (InsPost 33 ± 6% vs. Ctr 52 ± 4%, p < 0.05.). This cardioprotection was abrogated by co-administering SH-6, rapamycin, 5-HD, or MPG. (InsPost + SH-6 56 ± 9%, InsPost + Rapa 55 ± 8%, InsPost + 5-HD 56 ± 7%, InsPost + MPG 60 ± 3% vs. InsPost 33 ± 6% p < 0.05). These results were corroborated by a significant increase in phosphorylated Akt and p70s6k in the InsPost group compared with controls.
CONCLUSION: Short intermittent insulin infusions can mimic ischemic postconditioning and reduce myocardial infarct size via Akt/p70s6k and mKATP channels/ROS-dependent signaling.

Entities:  

Keywords:  RISK; ROS; cardioprotection; insulin; ischemia; postconditioning; reperfusion injury; reperfusion therapy

Mesh:

Substances:

Year:  2015        PMID: 26156031     DOI: 10.3109/14017431.2015.1071494

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  2 in total

1.  Impact of Administration Time and Kv7 Subchannels on the Cardioprotective Efficacy of Kv7 Channel Inhibition.

Authors:  Jan Hansen; Jacob Johnsen; Jan Møller Nielsen; Charlotte Brandt Sørensen; Casper Carlsen Elkjær; Nichlas Riise Jespersen; Hans Erik Bøtker
Journal:  Drug Des Devel Ther       Date:  2020-07-02       Impact factor: 4.162

Review 2.  Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration.

Authors:  J A Epps; N A Smart
Journal:  Cardiovasc Diabetol       Date:  2016-09-09       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.